Cargando…

Immunoadsorption Therapy for Patients with Dilated Cardiomyopathy and Heart Failure

Several autoantibodies directed against cardiac cellular proteins including G-protein-linked receptors, contractile proteins and mitochondrial proteins, have been identified in patients with dilated cardiomyopathy (DCM). Among these autoantibodies, anti-β1-adrenoreceptor (AR) antibodies have long be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ikeda, Uichi, Kasai, Hiroki, Izawa, Atsushi, Koyama, Jun, Yazaki, Yoshikazu, Takahashi, Masafumi, Higuchi, Makoto, Koh, Chang-Sung, Yamamoto, Keiji
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers Ltd. 2008
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780823/ https://www.ncbi.nlm.nih.gov/pubmed/19936198 http://dx.doi.org/10.2174/157340308785160534

Ejemplares similares

Immunoadsorption in dilated cardiomyopathy
por: Wakabayashi, Y, et al.
Publicado: (2009)

Immunoadsorption therapy in refractory heart failure patients with dilated cardiomyopathy: a potential therapeutic option*
por: Cavusoglu, Yuksel, et al.
Publicado: (2023)

Immunoadsorption treatment for dilated cardiomyopathy: A PRISMA-compliant systematic review and meta-analysis
por: Bian, Ru-tao, et al.
Publicado: (2021)

Use of Cardiac Biomarkers for Monitoring Improvement of Left Ventricular Function by Immunoadsorption Treatment in Dilated Cardiomyopathy
por: Weinmann, Karolina, et al.
Publicado: (2019)

Immunoadsorption therapy for dilated cardiomyopathy using tryptophan column—A prospective, multicenter, randomized, within‐patient and parallel‐group comparative study to evaluate efficacy and safety
por: Yoshikawa, Tsutomu, et al.
Publicado: (2016)

Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy
por: Ameling, Sabine, et al.
Publicado: (2013)

Changes of myocardial gene expression and protein composition in patients with dilated cardiomyopathy after immunoadsorption with subsequent immunoglobulin substitution
por: Ameling, Sabine, et al.
Publicado: (2016)

Erratum to: Changes of myocardial gene expression and protein composition in patients with dilated cardiomyopathy after immunoadsorption with subsequent immunoglobulin substitution
por: Ameling, Sabine, et al.
Publicado: (2017)

Crucial Role of Hyaluronan in Neointimal Formation after Vascular Injury
por: Kashima, Yuichiro, et al.
Publicado: (2013)

Heart failure in dilated non-ischaemic cardiomyopathy
por: Seferović, Petar M, et al.
Publicado: (2019)

Immunoadsorption Column Reuse
por: Tiwari, Vaibhav, et al.
Publicado: (2021)

Genetics and genomics of dilated cardiomyopathy and systolic heart failure
por: Tayal, Upasana, et al.
Publicado: (2017)

Mortality risk in dilated cardiomyopathy: the accuracy of heart failure prognostic models and dilated cardiomyopathy‐tailored prognostic model
por: Dziewięcka, Ewa, et al.
Publicado: (2020)

Immunoadsorption therapy in autoimmune encephalitides
por: Dogan Onugoren, Müjgan, et al.
Publicado: (2016)

Immunoadsorption and covid 19 pandemic
por: Tseke, Paraskevi, et al.
Publicado: (2022)

Survival benefit of ghrelin in the heart failure due to dilated cardiomyopathy
por: Du, Cheng-Kun, et al.
Publicado: (2014)

Maintaining Success for Patients With Dilated Cardiomyopathy and Remission of Heart Failure
por: Halliday, Brian P., et al.
Publicado: (2022)

Real-world Practical Experience of Angiotensin Receptor-neprilysin Inhibitor in Older Japanese Patients with Chronic Heart Failure
por: Komatsu, Toshinori, et al.
Publicado: (2023)

Clinical Impact of Rapid Reduction of Low-Density Lipoprotein Cholesterol Level on Long-Term Outcome of Acute Myocardial Infarction in the Statin Era: Subanalysis of the ALPS-AMI Study
por: Miura, Takashi, et al.
Publicado: (2015)

Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart
por: Bollen, Ilse A. E., et al.
Publicado: (2015)

Prevalence of Anemia in Children with Congestive Heart Failure due to Dilated Cardiomyopathy
por: Mueller, Goetz Christoph, et al.
Publicado: (2012)

Induction of Ankrd1 in Dilated Cardiomyopathy Correlates with the Heart Failure Progression
por: Bogomolovas, Julius, et al.
Publicado: (2015)

Myocarditis in Paediatric Patients: Unveiling the Progression to Dilated Cardiomyopathy and Heart Failure
por: Farinha, Inês Teixeira, et al.
Publicado: (2016)

Metabolomics Fingerprint Predicts Risk of Death in Dilated Cardiomyopathy and Heart Failure
por: Vignoli, Alessia, et al.
Publicado: (2022)

Late gadolinium enhancement for re‐worsening left ventricular ejection fraction in patients with dilated cardiomyopathy
por: Nabeta, Takeru, et al.
Publicado: (2020)

Heart Failure Phenotypes Induced by Knockdown of DAPIT in Zebrafish: A New Insight into Mechanism of Dilated Cardiomyopathy
por: Nagata, Yoji, et al.
Publicado: (2017)

Partial purification of presynaptic plasma membrane by immunoadsorption
Publicado: (1982)

Native T1 high region and left ventricular ejection fraction recovery in patients with dilated cardiomyopathy
por: Yazaki, Mayu, et al.
Publicado: (2023)

Silent cerebral infarction in chronic heart failure: Ischemic and nonischemic dilated cardiomyopathy
por: Kozdag, Guliz, et al.
Publicado: (2008)

Bmi1 limits dilated cardiomyopathy and heart failure by inhibiting cardiac senescence
por: Gonzalez-Valdes, I., et al.
Publicado: (2015)

Identification of Potential Gene Interactions in Heart Failure Caused by Idiopathic Dilated Cardiomyopathy
por: Huang, Huijuan, et al.
Publicado: (2018)

Immune-inflammatory concept of the pathogenesis of chronic heart failure in dogs with dilated cardiomyopathy
por: Vatnikov, Yu, et al.
Publicado: (2019)

Nemaline myopathy with dilated cardiomyopathy and severe heart failure: A case report
por: Wang, Qian, et al.
Publicado: (2021)

Choroidal thickness changes in children with chronic heart failure due to dilated cardiomyopathy
por: Rakusiewicz, Klaudia, et al.
Publicado: (2021)

Dilated Cardiomyopathy and Systolic Heart Failure in a Female Patient With Danon Disease
por: Stack-Pyle, Taylor J, et al.
Publicado: (2022)

Rodent Models of Dilated Cardiomyopathy and Heart Failure for Translational Investigations and Therapeutic Discovery
por: Ponzoni, Matteo, et al.
Publicado: (2023)

Importance of Fatty Acid Compositions in Patients with Peripheral Arterial Disease
por: Gautam, Milan, et al.
Publicado: (2014)

Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction
por: Hioki, Hirofumi, et al.
Publicado: (2015)

Clinical significance of left atrial geometry in dilated cardiomyopathy patients: A cardiovascular magnetic resonance study
por: Yazaki, Mayu, et al.
Publicado: (2020)

Dilated cardiomyopathy
por: Schultheiss, Heinz-Peter, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_146r9l888vrancs3r8moap8ugm